Stock Scorer

Bio Green Med Solution, Inc. (BGMS)

Bio Green Med Solution, Inc. reported revenue of 336K USD for the quarter ending 30 June 2026.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 336K —
Operating Income Q2 '26 · ending 30 June 2026 -418K —
Net Income Q2 '26 · ending 30 June 2026 -405K —
Operating Cash Flow Q2 '26 · ending 30 June 2026 -352K —
Free Cash Flow Q2 '26 · ending 30 June 2026 -352K —
Shares Outstanding Q2 '26 · ending 30 June 2026 5.6M +1432.9%
EPS Q4 '25 · ending 31 December 2025 -5.88 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 747K-8.4M-3M—
20242024-12-31 43K-12M-11.2M—
20232023-12-31 420K-25.5M-22.6M-16.1M
20222022-12-31 0-27.7M-21.2M-20.8M
20212021-12-31 0-22.4M-18.5M-18.6M
20202020-12-31 0-10.6M-8.4M-8M
20182018-12-31 150K-9.5M-7.3M-6.7M
20172017-12-31 0-9.5M-7.5M-7.5M
20162016-12-31 843K-14.2M-11.8M-10.1M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30336K
Q1 '262026-03-31778K
Q4 '252025-12-31666K
Q3 '252025-09-3081K
Q4 '242024-12-310
Q3 '242024-09-3010K
Q2 '242024-06-304K
Q1 '242024-03-3129K
Q4 '232023-12-3131K
Q3 '232023-09-3016K
Q2 '232023-06-30373K
Q1 '232023-03-310
Q4 '222022-12-310
Q3 '222022-09-300
Q2 '222022-06-300
Q1 '222022-03-310
Q4 '212021-12-310
Q3 '212021-09-300
Q2 '212021-06-300
Q1 '212021-03-310

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-418K
Q1 '262026-03-31-246K
Q4 '252025-12-31-1.1M
Q3 '252025-09-30-992K
Q2 '252025-06-30-68K
Q1 '252025-03-31-822K
Q4 '242024-12-31-1.8M
Q3 '242024-09-30-2.2M
Q2 '242024-06-30-3.6M
Q1 '242024-03-31-4.4M
Q4 '232023-12-31-5.4M
Q3 '232023-09-30-6.8M
Q2 '232023-06-30-5.9M
Q1 '232023-03-31-7.3M
Q4 '222022-12-31-8.8M
Q3 '222022-09-30-6.5M
Q2 '222022-06-30-5.8M
Q1 '222022-03-31-6.6M
Q4 '212021-12-31-6.3M
Q3 '212021-09-30-6M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-405K
Q1 '262026-03-31-197K
Q4 '252025-12-31-611K
Q3 '252025-09-30-988K
Q2 '252025-06-30-1.3M
Q1 '252025-03-31-81K
Q4 '242024-12-31-3.1M
Q3 '242024-09-30-2M
Q2 '242024-06-30-3.3M
Q1 '242024-03-31-2.9M
Q4 '232023-12-31-5.3M
Q3 '232023-09-30-6M
Q2 '232023-06-30-5.4M
Q1 '232023-03-31-5.8M
Q4 '222022-12-31-7.4M
Q3 '222022-09-30-5.1M
Q2 '222022-06-30-4.6M
Q1 '222022-03-31-4.1M
Q4 '212021-12-31-5.1M
Q3 '212021-09-30-5M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-352K
Q1 '262026-03-31-278K
Q4 '252025-12-31-33K
Q3 '252025-09-30-434K
Q2 '252025-06-30-1.1M
Q1 '252025-03-31-3.2M
Q4 '242024-12-31-1.4M
Q3 '242024-09-30-3.1M
Q2 '242024-06-30-3.1M
Q1 '242024-03-31-483K
Q4 '232023-12-31-3.9M
Q3 '232023-09-30-4M
Q2 '232023-06-30-1.3M
Q1 '232023-03-31-6.9M
Q4 '222022-12-31-5.2M
Q3 '222022-09-30-7M
Q2 '222022-06-30-1.9M
Q1 '222022-03-31-6.8M
Q4 '212021-12-31-4.5M
Q3 '212021-09-30-6.2M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-352K
Q1 '262026-03-31-279K
Q3 '242024-09-30-3.1M
Q4 '232023-12-31-3.9M
Q3 '232023-09-30-4M
Q2 '232023-06-30-1.3M
Q1 '232023-03-31-6.9M
Q4 '222022-12-31-5.2M
Q3 '222022-09-30-7M
Q2 '222022-06-30-1.9M
Q1 '222022-03-31-6.8M
Q4 '212021-12-31-4.6M
Q3 '212021-09-30-6.2M
Q2 '212021-06-30-4.3M
Q1 '212021-03-31-3.6M
Q4 '202020-12-31-1.2M
Q3 '202020-09-30-2.2M
Q2 '202020-06-30-1.8M
Q1 '202020-03-31-2.8M
Q4 '192019-12-31-1.1M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-305.6M
Q1 '262026-03-315.5M
Q3 '252025-09-301.9M
Q2 '252025-06-301.4M
Q1 '252025-03-31365.2K
Q3 '242024-09-3044.7K
Q2 '232023-06-3012.6M
Q1 '232023-03-3112.5M
Q3 '222022-09-3012.3M
Q2 '222022-06-3010.1M
Q1 '222022-03-3110M
Q3 '212021-09-309.4M
Q2 '212021-06-309.2M
Q1 '212021-03-317M
Q2 '142014-06-3022.6M
Q1 '142014-03-3119.5M
Q3 '132013-09-3017.8M
Q2 '132013-06-3013.9M
Q1 '132013-03-319.8M
Q3 '122012-09-308.4M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q4 '252025-12-31-5.88
Q3 '252025-09-30-14.74
Q2 '252025-06-30-57.23
Q1 '252025-03-31-228.43
Q4 '242024-12-31-230.70
Q4 '222022-12-31-27.25
Q3 '222022-09-30-1.81
Q2 '222022-06-30-1.93
Q1 '222022-03-31-2.03
Q4 '212021-12-31-2.11
Q3 '212021-09-30-3.21
Q2 '212021-06-30-3.14
Q1 '212021-03-31-3.16
Q4 '202020-12-31-4.14
Q3 '202020-09-30-5.29
Q2 '202020-06-30-7.09
Q1 '202020-03-31-8.64
Q4 '192019-12-31-9.93
Q3 '192019-09-30-7.34
Q2 '192019-06-30-5.25